301 related articles for article (PubMed ID: 22338196)
21. [Selective blockade of the mutated BRAF leads to a survival benefit in patients with metastatic melanoma].
Schadendorf D
J Dtsch Dermatol Ges; 2011 Apr; 9(4):340. PubMed ID: 21439018
[No Abstract] [Full Text] [Related]
22. [Investigational treatment of cancer using electrochemotherapy, electrochemoimmunotherapy and electro-gene transfer].
Gehl J
Ugeskr Laeger; 2005 Aug; 167(34):3156-9. PubMed ID: 16117912
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic factors and improving treatment of cutaneous melanoma].
Vihinen P; Kähäri VM; Pyrhönen S
Duodecim; 2004; 120(12):1445-56. PubMed ID: 15293705
[No Abstract] [Full Text] [Related]
24. Tetraspanin8 expression predicts an increased metastatic risk and is associated with cancer-related death in human cutaneous melanoma.
Berthier-Vergnes O; Barbollat-Boutrand L; Pommier RM; de la Fouchardière A; Combemale P; Grimont M; Lopez-Ramirez N; Caramel J; Dalle S; Perrot JL; Gaudy-Marqueste C; Macagno N; Mansard S; Bouquet F; Masse I
Mol Cancer; 2021 Oct; 20(1):127. PubMed ID: 34600553
[No Abstract] [Full Text] [Related]
25. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
26. Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
Held L; Eigentler TK; Meier F; Held M; Röcken M; Garbe C; Bauer J
J Dtsch Dermatol Ges; 2011 Jul; 9(7):510-6. PubMed ID: 21244632
[TBL] [Abstract][Full Text] [Related]
27. Combination immunotherapy breakthrough for melanoma.
Brower V
Lancet Oncol; 2015 Jul; 16(7):e318. PubMed ID: 26062775
[No Abstract] [Full Text] [Related]
28. [Vaccination therapy of melanoma].
Schuler-Thurner B; Schuler G
J Dtsch Dermatol Ges; 2005 Aug; 3(8):630-45. PubMed ID: 16033483
[No Abstract] [Full Text] [Related]
29. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
30. Melanoma treatment's changing landscape.
Jenks S
J Natl Cancer Inst; 2014 Jun; 106(6):dju176. PubMed ID: 24907389
[No Abstract] [Full Text] [Related]
31. [Melanoma and search for therapeutic targets].
de la Fouchardière A
Ann Pathol; 2011 Nov; 31(5 Suppl):S123-4. PubMed ID: 22054449
[No Abstract] [Full Text] [Related]
32. The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis.
Rulli E; Legramandi L; Salvati L; Mandala M
Cancer; 2019 Nov; 125(21):3776-3789. PubMed ID: 31287564
[TBL] [Abstract][Full Text] [Related]
33. Melanoma: understanding relevant molecular pathways as well as available and emerging therapies.
McKibbin T
Am J Manag Care; 2015 Sep; 21(10 Suppl):S224-33. PubMed ID: 26619296
[TBL] [Abstract][Full Text] [Related]
34. Combinatorial approach to treatment of melanoma.
Ashworth MT; Daud AI
Hematol Oncol Clin North Am; 2014 Jun; 28(3):601-12. PubMed ID: 24880950
[TBL] [Abstract][Full Text] [Related]
35. [Consensus conference. Follow-up of patients surgically treated for stage I melanoma].
Ann Dermatol Venereol; 1995; 122(5):250-8. PubMed ID: 8572461
[No Abstract] [Full Text] [Related]
36. Combination Therapies for Melanoma: A New Standard of Care?
Smalley KS; Eroglu Z; Sondak VK
Am J Clin Dermatol; 2016 Apr; 17(2):99-105. PubMed ID: 26860106
[TBL] [Abstract][Full Text] [Related]
37. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
[TBL] [Abstract][Full Text] [Related]
38. Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients.
Gimotty PA; Guerry D; Flaherty K
J Clin Oncol; 2008 Feb; 26(4):517-8. PubMed ID: 18235111
[No Abstract] [Full Text] [Related]
39. SEOM clinical guideline for the management of cutaneous melanoma (2020).
Majem M; Manzano JL; Marquez-Rodas I; Mujika K; Muñoz-Couselo E; Pérez-Ruiz E; de la Cruz-Merino L; Espinosa E; Gonzalez-Cao M; Berrocal A
Clin Transl Oncol; 2021 May; 23(5):948-960. PubMed ID: 33651321
[TBL] [Abstract][Full Text] [Related]
40. Targeted Therapies in Melanoma: Translational Research at Its Finest.
Ho AW; Tsao H
J Invest Dermatol; 2015 Aug; 135(8):1929-1933. PubMed ID: 26174532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
